NCT03555214

Brief Summary

Introduction According to the World Health Organization (WHO) at least 47% of adults have suffered from headache in the last year. The headache is not only painful but also disabling, it can be accompanied by social and personal problems, with a decrease in the quality of life and with economic losses. Migraine affects a large number of people and, if the predisposing factors are not controlled, it can become chronic. Once the chronification point of migraine has arrived, it seriously affects the quality of life of people, both in the workplace, social and leisure. objective Perform the application of a manual therapy treatment based on protocols that include techniques already proven to improve different areas of impact in patients with migraine. To evaluate various aspects, we will include the intensity of pain, the frequency of episodes, anxiety and depression, quality of life, etc ... and the limitations or disability that it produces. Material and methods This is a prospective, single-blind, randomized study with patients diagnosed with migraine. The sample will be distributed in 4 groups: a) experimental group that will receive combined treatment of soft tissues with techniques evidenced independently; b) Group that will receive independent structural techniques; c) the group that will receive the set of protocols a and b; d) and the placebo control group. Evaluation An initial assessment will be carried out, another at the end of the treatment and another follow-up one month after the end of the treatment. In addition, the evaluation will include the following instruments: the HDI scale (Headache Disability Inventory), the MIDAS scale (Migraine Disability Assessment Scale), the SF-36 Questionnaire, the EVA Scale (Visual-Analogue Scale), the HIT-6 Questionnaire, the BDI Questionnaire (Beck Inventory Depression), the STAI Questionnaire (The State-Trait Anxiety Inventory), the change perceived after the treatment and medication intake.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 13, 2018

Completed
17 days until next milestone

Study Start

First participant enrolled

June 30, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2018

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 3, 2019

Completed
Last Updated

April 14, 2020

Status Verified

April 1, 2020

Enrollment Period

4 months

First QC Date

May 31, 2018

Last Update Submit

April 13, 2020

Conditions

Keywords

migrainemanual therapy

Outcome Measures

Primary Outcomes (1)

  • Intensity of Pain

    Visual Analog Scale. It is a commonly used and validated instrument in the interpretation of pain intensity. In a line of 10 cm, divided by numbers from 0 to 10, the patient marks the intensity of the pain, being 0 "absence of pain" and 10 "worst pain imaginable".

    8 weeks

Secondary Outcomes (8)

  • Disability

    8 weeks

  • Health status

    8 weeks

  • Headache Impact

    8 weeks

  • Depression

    8 weeks

  • Change perceived after treatment

    8 weeks

  • +3 more secondary outcomes

Study Arms (4)

Manual Therapy based on soft tissue

EXPERIMENTAL
Other: Manual Therapy based on soft tissues

Control Group

PLACEBO COMPARATOR
Other: Control group

Manual Therapy based on structural techniques

EXPERIMENTAL
Other: Manual Therapy based on structural techniques

Manual Therapy based on soft tissue and structural techniques

EXPERIMENTAL
Other: Manual Therapy based on soft tissues and structural techniques

Interventions

Manual Therapy: 1. Technique of suboccipital inhibition. 2. Cranial frontal technique. 3. Cranial sphenoid technique. 4. Cranial fourth ventricle technique. 5. Antero-posterior abdominal-sacral technique.

Manual Therapy based on soft tissue

Placebo treatment: The patient remains supine and the therapist sits on a stool at the bedside with the forearms resting on the couch. Both hands are placed on the posterolateral part of the patient's head and the position is maintained for 10 minutes without exerting any force or movement.

Control Group

Manual Therapy: 1. Technique of manipulation of the occipito-atlanto-axoidea joint (OAA). 2. Articulation technique of the high cervical spine (C0-C1). 3. Postero-anterior articular technique of C2-C7 in supine position. 4. Postero-anterior articular technique of C2-C7 in prone position. 5. Manipulative technique of the flapper C7-T1. 6. Dorsal spinal manipulative technique (T1-T8). 7. Lumbosacral global manipulative technique.

Manual Therapy based on structural techniques

Manual Therapy: 1. Technique of suboccipital inhibition. 2. Cranial frontal technique. 3. Cranial sphenoid technique. 4. Cranial fourth ventricle technique. 5. Antero-posterior abdominal-sacral technique. 6. Technique of manipulation of the occipito-atlanto-axoidea joint (OAA). 7. Articulation technique of the high cervical spine (C0-C1). 8. Postero-anterior articular technique of C2-C7 in supine position. 9. Postero-anterior articular technique of C2-C7 in prone position. 10. Manipulative technique of the flapper C7-T1. 11. Dorsal spinal manipulative technique (T1-T8). 12. Lumbosacral global manipulative technique.

Manual Therapy based on soft tissue and structural techniques

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Have at least 4 migrainous crises per month, following the criteria established by the IHS
  • history of episodes of more than a year of evolution
  • use of stable medication during the four weeks prior to the start of the study
  • between 18 and 60 years old

You may not qualify if:

  • currently being in physiotherapy preventive treatment
  • being in the process of pharmacological adaptation
  • have artery-vertebral involvement problems (bone degeneration, metabolic or musculoskeletal problems that involve vertebral artery risk)
  • suffer from dizziness
  • suffering dizziness or unbalanced tension.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physiotherapy

Valencia, 46010, Spain

Location

MeSH Terms

Conditions

Migraine Disorders

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 31, 2018

First Posted

June 13, 2018

Study Start

June 30, 2018

Primary Completion

October 30, 2018

Study Completion

December 3, 2019

Last Updated

April 14, 2020

Record last verified: 2020-04

Locations